LMWH - new mechanisms of action.
Harenberg
J
J
Clinical Pharmacology Mannheim, Faculty of Medicine Mannheim, Ruprecht-Karls-University Heidelberg, Germany. job.harenberg@medma.uni-heidelberg.de
D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D000925:Anticoagulants / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D006495:Heparin, Low-Molecular-Weight / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D009362:Neoplasm Metastasis / Q000188:drug therapy / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy; D011287:Prejudice; D019087:Selectins / Q000187:drug effects; D013923:Thromboembolism / Q000188:drug therapy
D020533:Angiogenesis Inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D000970:Antineoplastic Agents; D006495:Heparin, Low-Molecular-Weight; D019087:Selectins